Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Head & Neck 4CNS 4Breast 4Sarcoma 3Dermatologic 3Genitourinary 2Tumor-Agnostic 1Thoracic 1Classical hematology 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 95pembrolizumab 82Pemetrexed 74Cisplatin 60Specimen Handling 39durvalumab 36Paclitaxel 35Nivolumab 34Magnetic Resonance Spectroscopy 32osimertinib 26Docetaxel 25Gemcitabine 20Etoposide 20atezolizumab 19Radiotherapy 18Radiosurgery 18130-nm albumin-bound paclitaxel 17amivantamab 13Ipilimumab 13Taxes 11Radiation 10Drug Therapy 10Cetuximab 10Bevacizumab 10lazertinib 9Ramucirumab 9Platinum 9Immunoglobulin G 9Disulfides 9cemiplimab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Surgical Procedures, Operative × Thoracic × 30 days × Clear all
NCT06632327 2026-05-08

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
1,100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡